Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?
Authors
Keywords
Breast cancer, Brain metastasis, Risk factors, Multilevel diagnostics, Patient stratification, Predictive preventive and personalised medicine
Journal
EPMA Journal
Volume 8, Issue 2, Pages 119-127
Publisher
Springer Nature
Online
2017-03-13
DOI
10.1007/s13167-017-0087-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
- (2016) Onder Tonyali et al. BREAST
- Targeted Therapies for Brain Metastases from Breast Cancer
- (2016) Vyshak Venur et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures
- (2016) Olga Golubnitschaja et al. TUMOR BIOLOGY
- Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
- (2016) Olga Golubnitschaja et al. EPMA Journal
- Breast Cancer Subtypes Predispose the Site of Distant Metastases
- (2015) Abha Soni et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Identifying risk factors for brain metastasis in breast cancer patients: Implication for a vigorous surveillance program
- (2015) Lorraine Chow et al. Asian Journal of Surgery
- Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
- (2015) Jiri Polivka et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
- (2015) Xavier Pivot et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases
- (2015) Ishwaria M. Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- (2015) P. K. Brastianos et al. Cancer Discovery
- Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
- (2014) S. M. Swain et al. ANNALS OF ONCOLOGY
- Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
- (2014) Anna S. Berghoff et al. BREAST
- Role of the Neural Niche in Brain Metastatic Cancer
- (2014) J. Termini et al. CANCER RESEARCH
- Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network
- (2014) Bahrami Tayyeb et al. MOLECULAR NEUROBIOLOGY
- Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients
- (2014) Man-Hsin Hung et al. PLoS One
- Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis
- (2014) Bodour Salhia et al. PLoS One
- Human breast cancer metastases to the brain display GABAergic properties in the neural niche
- (2014) J. Neman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
- (2013) E. M. Olson et al. ANNALS OF ONCOLOGY
- Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: The role of Rad51
- (2013) Katarzyna Sosińska-Mielcarek et al. BREAST
- Co-evolution of breast-to-brain metastasis and neural progenitor cells
- (2013) Josh Neman et al. CLINICAL & EXPERIMENTAL METASTASIS
- B-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain
- (2013) D. Malin et al. CLINICAL CANCER RESEARCH
- Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain
- (2013) Hava Karsenty Avraham et al. JOURNAL OF PATHOLOGY
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
- (2013) Bernhard C Pestalozzi et al. LANCET ONCOLOGY
- Erratum: Integrated genomic analyses of ovarian carcinoma
- (2012) The Cancer Genome Atlas Research Network NATURE
- A nomogram for individualized estimation of survival among patients with brain metastasis
- (2012) J. S. Barnholtz-Sloan et al. NEURO-ONCOLOGY
- Retrospective Analysis of Risk Factors for Central Nervous System Metastases in Operable Breast Cancer: Effects of Biologic Subtype and Ki67 Overexpression on Survival
- (2012) Mikiya Ishihara et al. ONCOLOGY
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Predicting survival in women with breast cancer and brain metastasis
- (2011) Nicholas F. Marko et al. CANCER
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
- (2011) Paul W. Sperduto et al. JOURNAL OF CLINICAL ONCOLOGY
- Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer
- (2011) P. M. McGowan et al. MOLECULAR CANCER RESEARCH
- Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival
- (2010) F. Heitz et al. ANNALS OF ONCOLOGY
- Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer
- (2010) Olivier Graesslin et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
- (2009) Florian Heitz et al. EUROPEAN JOURNAL OF CANCER
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization
- (2008) Daniel P. Fitzgerald et al. CLINICAL & EXPERIMENTAL METASTASIS
- Activation of Notch Signaling in a Xenograft Model of Brain Metastasis
- (2008) D.-H. Nam et al. CLINICAL CANCER RESEARCH
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) I. J. Dahabreh et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now